Can a smartphone app curb HIV risk in south Korea's young gay men?

NCT ID NCT07741123

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This pilot trial tests a mobile app called Bandi, designed to support HIV prevention among young men who have sex with men in South Korea. Participants are randomly assigned to either the full app, which includes interactive health content, peer forums, a sexual health log, and a clinic finder, or a basic version with only informational articles and a clinic finder. Over three months, researchers compare the two groups to see if the full app leads to higher rates of HIV testing and lower sexual risk behaviors. The study aims to learn if the app is acceptable, easy to use, and helpful for this community.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bandi mobile application (full access) - a culturally adapted digital HIV prevention app with interactive content, peer forums, sexual health tracking, clinic locator, and gamification.
What this could lead to
If successful, this app could offer a scalable, engaging way to improve HIV prevention and sexual health among young men who have sex with men in South Korea.
What could go wrong
This is a small pilot study, so results may not be conclusive. The app's impact on HIV testing and risk behavior may be limited by user engagement or cultural fit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIGITAL HEALTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Risk Reduction Behavior Social Stigma HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ewha Womans University

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.